The significantly lower levels of IgM anti-tyrosinase autoantibodies are found in melanoma patients and in people with vitiligo, in comparison to that found in controls p < 0.0000004 and p < 0.04 respectively, as seen on Figure 1. This evidence concerns the gene TYR and vitiligo.